LYVE1 and myocardial infarction: In the heart, Lyve1+ resident macrophages act in a cardioprotective manner during myocardial infarction (Dick et al., 2019) and are immunoregulatory and promote engraftment of cardiac allografts (Thornley et al., 2014).